VisiPlate

Project Information

Problem

Glaucoma is the leading cause of irreversible blindness worldwide. Minimally invasive surgeries are not efficacious at sustaining lower IOP while more effective implants (tube shunts) are invasive and carry greater post-operative risks.

Solution

VisiPlate is a nanoscale aqueous shunt implanted in the subconjunctival space.

Technology Type

Diagnostic

Aids with identifying the nature and cause(s) of a clinical problem or illness

Facilitator

Increases the efficacy of a clinical process or procedure

Therapeutic

Enables healing from or treatment of an illness or clinical problem

Monitor

Records/shares data as on-going surveillance of a clinical problem, process or procedure

PI/Inventor(s)

Brandon Kao

CTO, Co-Founder of Avisi

Rui Jing Jiang

CEO, Co-Founder of Avisi

Company Formed

Cohort

2018-2019